Loading
Latest filing published 01 Feb 2022 for HOOKIPA Pharma Inc., €25k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Klaus Orlinger on record concern HOOKIPA Pharma Inc., in the capacity of senior executive. The record holds 10 filings, for trades running from 14 January 2020 to 1 February 2022.
Sales make up the whole of the open-market record (3 sales, €178k). Outside the open market, there are 2 share grants and 5 option exercises.
On 1 February 2022 came the latest disclosure, a share grant for €25k in HOOKIPA Pharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration